Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A recapitalization plan would end News Corp’s dual-class share structure, which gives the Murdoch family outsized control of the company.
FERC kiboshed a bid to increase the amount of power that a nuclear plant in Pennsylvania is allowed to supply to one of Amazon’s data centers.
Autonomy has been a part of Tesla’s vision for a long time, with its recent focus on robotaxis doubling down on the market.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Last week the Big Oil companies weighed in with their earnings reports, and it was mostly a pretty sorry assembly.
Music streaming services that offer more or less all the recorded music in history. So how is the industry supposed to grow?
Peloton announced that it has appointed Peter Stern as CEO and president to pedal the company out of its prolonged post-pandemic slump.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The cost of manufacturing chocolate and confectionery from cocoa has risen a terrifying 45% this year, according to the producer price index.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
Chinese electric vehicle giant BYD announced revenue of just over $28 billion in the three months ending September.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.